GILEAD SCIENCES INC (GILD) Stock Fundamental Analysis

NASDAQ:GILD • US3755581036

151.12 USD
-1.62 (-1.06%)
At close: Feb 19, 2026
151.68 USD
+0.56 (+0.37%)
After Hours: 2/19/2026, 8:04:31 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

GILD gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 521 industry peers in the Biotechnology industry. While GILD belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. GILD has a decent growth rate and is not valued too expensively. Finally GILD also has an excellent dividend rating. This makes GILD very considerable for dividend investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • GILD had positive earnings in the past year.
  • In the past year GILD had a positive cash flow from operations.
  • Each year in the past 5 years GILD has been profitable.
  • GILD had a positive operating cash flow in 4 of the past 5 years.
GILD Yearly Net Income VS EBIT VS OCF VS FCFGILD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

1.2 Ratios

  • GILD's Return On Assets of 13.86% is amongst the best of the industry. GILD outperforms 94.82% of its industry peers.
  • GILD has a better Return On Equity (37.80%) than 98.08% of its industry peers.
  • GILD has a better Return On Invested Capital (19.16%) than 97.50% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for GILD is in line with the industry average of 18.69%.
  • The last Return On Invested Capital (19.16%) for GILD is above the 3 year average (17.57%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 13.86%
ROE 37.8%
ROIC 19.16%
ROA(3y)8.12%
ROA(5y)8.16%
ROE(3y)21.64%
ROE(5y)23.22%
ROIC(3y)17.58%
ROIC(5y)16.77%
GILD Yearly ROA, ROE, ROICGILD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

1.3 Margins

  • GILD's Profit Margin of 27.88% is amongst the best of the industry. GILD outperforms 95.39% of its industry peers.
  • GILD's Profit Margin has improved in the last couple of years.
  • The Operating Margin of GILD (38.96%) is better than 98.27% of its industry peers.
  • GILD's Operating Margin has been stable in the last couple of years.
  • GILD's Gross Margin of 78.72% is amongst the best of the industry. GILD outperforms 85.22% of its industry peers.
  • GILD's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 38.96%
PM (TTM) 27.88%
GM 78.72%
OM growth 3Y-1.28%
OM growth 5Y-0.04%
PM growth 3Y19.75%
PM growth 5Y125.27%
GM growth 3Y-0.18%
GM growth 5Y-0.66%
GILD Yearly Profit, Operating, Gross MarginsGILD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so GILD is creating value.
  • The number of shares outstanding for GILD has been reduced compared to 1 year ago.
  • GILD has less shares outstanding than it did 5 years ago.
  • There is no outstanding debt for GILD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
GILD Yearly Shares OutstandingGILD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
GILD Yearly Total Debt VS Total AssetsGILD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

  • GILD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACC2.32
WACC8.27%
GILD Yearly LT Debt VS Equity VS FCFGILD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.3 Liquidity

  • GILD has a Current Ratio of 1.53. This is a normal value and indicates that GILD is financially healthy and should not expect problems in meeting its short term obligations.
  • GILD has a worse Current ratio (1.53) than 80.42% of its industry peers.
  • A Quick Ratio of 1.17 indicates that GILD should not have too much problems paying its short term obligations.
  • GILD's Quick ratio of 1.17 is on the low side compared to the rest of the industry. GILD is outperformed by 83.30% of its industry peers.
Industry RankSector Rank
Current Ratio 1.53
Quick Ratio 1.17
GILD Yearly Current Assets VS Current LiabilitesGILD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 76.79% over the past year.
  • The Earnings Per Share has been growing slightly by 2.83% on average over the past years.
  • Looking at the last year, GILD shows a small growth in Revenue. The Revenue has grown by 2.40% in the last year.
  • The Revenue has been growing slightly by 3.58% on average over the past years.
EPS 1Y (TTM)76.79%
EPS 3Y3.88%
EPS 5Y2.83%
EPS Q2Q%-2.11%
Revenue 1Y (TTM)2.4%
Revenue growth 3Y2.57%
Revenue growth 5Y3.58%
Sales Q2Q%4.7%

3.2 Future

  • GILD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.47% yearly.
  • The Revenue is expected to grow by 4.32% on average over the next years.
EPS Next Y9.44%
EPS Next 2Y8.64%
EPS Next 3Y8.05%
EPS Next 5Y8.47%
Revenue Next Year3.45%
Revenue Next 2Y4.63%
Revenue Next 3Y4.54%
Revenue Next 5Y4.32%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
GILD Yearly Revenue VS EstimatesGILD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B
GILD Yearly EPS VS EstimatesGILD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 18.54 indicates a rather expensive valuation of GILD.
  • Compared to the rest of the industry, the Price/Earnings ratio of GILD indicates a rather cheap valuation: GILD is cheaper than 94.82% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.09. GILD is valued slightly cheaper when compared to this.
  • The Price/Forward Earnings ratio is 16.94, which indicates a correct valuation of GILD.
  • 94.63% of the companies in the same industry are more expensive than GILD, based on the Price/Forward Earnings ratio.
  • GILD is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 27.98, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 18.54
Fwd PE 16.94
GILD Price Earnings VS Forward Price EarningsGILD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • 95.59% of the companies in the same industry are more expensive than GILD, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 19.69
EV/EBITDA N/A
GILD Per share dataGILD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates GILD does not grow enough to justify the current Price/Earnings ratio.
  • The excellent profitability rating of GILD may justify a higher PE ratio.
PEG (NY)1.96
PEG (5Y)6.56
EPS Next 2Y8.64%
EPS Next 3Y8.05%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. Dividend

5.1 Amount

  • GILD has a Yearly Dividend Yield of 2.15%.
  • Compared to an average industry Dividend Yield of 1.17, GILD pays a better dividend. On top of this GILD pays more dividend than 98.46% of the companies listed in the same industry.
  • GILD's Dividend Yield is comparable with the S&P500 average which is at 1.85.
Industry RankSector Rank
Dividend Yield 2.15%

5.2 History

  • The dividend of GILD has a limited annual growth rate of 4.45%.
  • GILD has been paying a dividend for at least 10 years, so it has a reliable track record.
  • GILD has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)4.45%
Div Incr Years9
Div Non Decr Years9
GILD Yearly Dividends per shareGILD Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

  • 12.00% of the earnings are spent on dividend by GILD. This is a low number and sustainable payout ratio.
  • The dividend of GILD is growing, but earnings are growing more, so the dividend growth is sustainable.
DP12%
EPS Next 2Y8.64%
EPS Next 3Y8.05%
GILD Yearly Income VS Free CF VS DividendGILD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B
GILD Dividend Payout.GILD Dividend Payout, showing the Payout Ratio.GILD Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

GILEAD SCIENCES INC

NASDAQ:GILD (2/19/2026, 8:04:31 PM)

After market: 151.68 +0.56 (+0.37%)

151.12

-1.62 (-1.06%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-10
Earnings (Next)04-22
Inst Owners91.58%
Inst Owner Change0.12%
Ins Owners0.07%
Ins Owner Change0.67%
Market Cap187.49B
Revenue(TTM)29.44B
Net Income(TTM)8.11B
Analysts81.62
Price Target142.32 (-5.82%)
Short Float %1.91%
Short Ratio3.15
Dividend
Industry RankSector Rank
Dividend Yield 2.15%
Yearly Dividend3.14
Dividend Growth(5Y)4.45%
DP12%
Div Incr Years9
Div Non Decr Years9
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.14%
Min EPS beat(2)0.6%
Max EPS beat(2)13.68%
EPS beat(4)3
Avg EPS beat(4)5.77%
Min EPS beat(4)-0.59%
Max EPS beat(4)13.68%
EPS beat(8)6
Avg EPS beat(8)10.36%
EPS beat(12)8
Avg EPS beat(12)8%
EPS beat(16)11
Avg EPS beat(16)5.39%
Revenue beat(2)1
Avg Revenue beat(2)0.99%
Min Revenue beat(2)-0.31%
Max Revenue beat(2)2.29%
Revenue beat(4)2
Avg Revenue beat(4)0.47%
Min Revenue beat(4)-3.96%
Max Revenue beat(4)3.87%
Revenue beat(8)5
Avg Revenue beat(8)1.32%
Revenue beat(12)8
Avg Revenue beat(12)1.67%
Revenue beat(16)12
Avg Revenue beat(16)2.95%
PT rev (1m)5.14%
PT rev (3m)9.72%
EPS NQ rev (1m)-2.64%
EPS NQ rev (3m)-3.29%
EPS NY rev (1m)-0.54%
EPS NY rev (3m)-0.41%
Revenue NQ rev (1m)0.26%
Revenue NQ rev (3m)0.64%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)0.54%
Valuation
Industry RankSector Rank
PE 18.54
Fwd PE 16.94
P/S 6.45
P/FCF 19.69
P/OCF 19.4
P/B 8.74
P/tB N/A
EV/EBITDA N/A
EPS(TTM)8.15
EY5.39%
EPS(NY)8.92
Fwd EY5.9%
FCF(TTM)7.67
FCFY5.08%
OCF(TTM)7.79
OCFY5.16%
SpS23.44
BVpS17.29
TBVpS-3.89
PEG (NY)1.96
PEG (5Y)6.56
Graham Number56.31
Profitability
Industry RankSector Rank
ROA 13.86%
ROE 37.8%
ROCE 24.51%
ROIC 19.16%
ROICexc 24.01%
ROICexgc 83.57%
OM 38.96%
PM (TTM) 27.88%
GM 78.72%
FCFM 32.73%
ROA(3y)8.12%
ROA(5y)8.16%
ROE(3y)21.64%
ROE(5y)23.22%
ROIC(3y)17.58%
ROIC(5y)16.77%
ROICexc(3y)21.93%
ROICexc(5y)20.23%
ROICexgc(3y)88.64%
ROICexgc(5y)94.14%
ROCE(3y)22.49%
ROCE(5y)21.46%
ROICexgc growth 3Y-8.52%
ROICexgc growth 5Y-2.51%
ROICexc growth 3Y8.92%
ROICexc growth 5Y10.03%
OM growth 3Y-1.28%
OM growth 5Y-0.04%
PM growth 3Y19.75%
PM growth 5Y125.27%
GM growth 3Y-0.18%
GM growth 5Y-0.66%
F-Score7
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 117.39%
Current Ratio 1.53
Quick Ratio 1.17
Altman-Z N/A
F-Score7
WACC8.27%
ROIC/WACC2.32
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)76.79%
EPS 3Y3.88%
EPS 5Y2.83%
EPS Q2Q%-2.11%
EPS Next Y9.44%
EPS Next 2Y8.64%
EPS Next 3Y8.05%
EPS Next 5Y8.47%
Revenue 1Y (TTM)2.4%
Revenue growth 3Y2.57%
Revenue growth 5Y3.58%
Sales Q2Q%4.7%
Revenue Next Year3.45%
Revenue Next 2Y4.63%
Revenue Next 3Y4.54%
Revenue Next 5Y4.32%
EBIT growth 1Y4.49%
EBIT growth 3Y1.26%
EBIT growth 5Y3.55%
EBIT Next Year16.04%
EBIT Next 3Y12.29%
EBIT Next 5Y8.69%
FCF growth 1Y0.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-3.54%
OCF growth 3YN/A
OCF growth 5YN/A

GILEAD SCIENCES INC / GILD FAQ

What is the ChartMill fundamental rating of GILEAD SCIENCES INC (GILD) stock?

ChartMill assigns a fundamental rating of 6 / 10 to GILD.


What is the valuation status for GILD stock?

ChartMill assigns a valuation rating of 5 / 10 to GILEAD SCIENCES INC (GILD). This can be considered as Fairly Valued.


How profitable is GILEAD SCIENCES INC (GILD) stock?

GILEAD SCIENCES INC (GILD) has a profitability rating of 8 / 10.


What is the valuation of GILEAD SCIENCES INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for GILEAD SCIENCES INC (GILD) is 18.54 and the Price/Book (PB) ratio is 8.74.


How sustainable is the dividend of GILEAD SCIENCES INC (GILD) stock?

The dividend rating of GILEAD SCIENCES INC (GILD) is 7 / 10 and the dividend payout ratio is 12%.